Reported about 11 hours ago
The Grifols family's troubles are back in focus following Brookfield Asset Management's withdrawal from its bid to take Grifols SA private. Once a beacon of medical success, Grifols now grapples with governance issues, heavy debt, and declining share prices after Brookfield's offer of €6.45 billion was rejected. As the family-led firm faces renewed scrutiny and struggles to manage its financial obligations, questions linger about its governance and future strategies amidst an uncertain market.
Source: YAHOO